Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$16.41
-4.29%
Mkt Cap $14.24B
Analyst Ratings
Buy
5
Hold
6
Sell
0
Price Target (26 analysts)
$26.86
Range $15.00 – $38.00
Implied Upside
+63.7%
Consensus $26.86 vs current $16.41
NASDAQ·Healthcare·Biotechnology
$16.41
-4.29%
Mkt Cap $14.24B
Buy
5
Hold
6
Sell
0
Price Target (26 analysts)
$26.86
Range $15.00 – $38.00
+63.7%
Consensus $26.86 vs current $16.41